Fig. 3From: Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized, double-blind, placebo-controlled trial and a 6-month open-label extension studyMean pain score by week in the double-blind trial. *P < 0.05 for pregabalin compared with placebo at each weekBack to article page